B-Cell Non-Hodgkins Lymphoma research hub

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

This study looks at a new way to give a treatment called glofitamab, along with gemcitabine and oxaliplatin, for a type of blood cancer called B-cell non-Hodgkin's lymphoma. The goal is to make the treatment safer and easier to get, potentially as an outpatient.